News
After four years, those who took GLP-1 drugs had a 7% lower risk of developing an obesity-related cancer and an 8% lower risk ...
Consumers are urged to understand which GLP-1 medications are safe, approved, and legal after May 22 If you're one of the ...
Newly recognized issues, including extreme fatigue with excessive weight reduction, bone loss, and abdominal pain, point to ...
New review confirms psychiatric safety of commonly used glucagon-like peptide 1 receptor agonists among patients without ...
After questions and criticism online, Janelle Rohner says she should have disclosed her decision to take a GLP-1.
1d
MedPage Today on MSNGLP-1 Agonists May Help Prevent Weight Gain for People Trying to Quit SmokingXavier said that patients are often reluctant to quit smoking because they are fearful that they will gain weight. By adding ...
6don MSN
Research on weight loss drugs like Ozempic shows varied results for mental health impacts, with some patients experiencing ...
25m
The Holy Mess on MSNGLP-1 Weight Loss Drugs: Miracle, Mess, or Something in Between?Unless you are from another planet, you’ve heard all about the new weight loss medications taking the world by storm. These ...
Dr. Rubinstein has years of experience working with patients to help them achieve their desired goals in a realistic, ...
India's healthtech space is expected to witness disruption as weight loss drugs Ozempic and Mounjaro enter the market through ...
Researchers found GLP-1s may modestly reduce the risk of 14 obesity-related cancers, especially colorectal cancer, when compared to a weight-neutral medication used to treat diabetes.
You’ve likely heard the hype around Ozempic and Wegovy – weight loss drugs that have taken the world by storm. These ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results